Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)
- PMID: 37225134
- DOI: 10.1055/s-0043-1769787
Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Erratum for
-
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS).Thromb Haemost. 2022 Sep;122(9):1612-1620. doi: 10.1055/a-1798-2400. Epub 2022 Mar 15. Thromb Haemost. 2022. PMID: 35292950
Similar articles
-
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS).Thromb Haemost. 2022 Sep;122(9):1612-1620. doi: 10.1055/a-1798-2400. Epub 2022 Mar 15. Thromb Haemost. 2022. PMID: 35292950
-
Antiphospholipid syndrome in pediatrics.Rheum Dis Clin North Am. 2007 Aug;33(3):499-523. doi: 10.1016/j.rdc.2007.07.001. Rheum Dis Clin North Am. 2007. PMID: 17936175
-
The Ped-APS Registry: the antiphospholipid syndrome in childhood.Lupus. 2009 Sep;18(10):894-9. doi: 10.1177/0961203309106917. Lupus. 2009. PMID: 19671789
-
Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS).Adv Rheumatol. 2020 May 27;60(1):29. doi: 10.1186/s42358-020-00125-9. Adv Rheumatol. 2020. PMID: 32460902 Review.
-
Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines.Expert Rev Hematol. 2021 May;14(5):457-466. doi: 10.1080/17474086.2021.1923474. Epub 2021 May 16. Expert Rev Hematol. 2021. PMID: 33909986 Review.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous